Table VI.
Frequency of amenorrhea and oligomenorrhea in 60 PCOS patients in three groups during 3 months
| Groups | Amenorrhea | Oligomenorrhea | Pregnancy | |||||
|---|---|---|---|---|---|---|---|---|
| Before n (%) | After n (%) | P€ | Before n (%) | After n (%) | P€ | After n (%) | ||
| Group 1 | Yes | 9 (45) | 4 (25) | 0.046 | 13 (65) | 5 (31.3) | 0.014 | 4 (18.2) |
| No | 11 (55) | 12 (75) | 7 (35) | 11 (68.7) | 18 (81.8) | |||
| Group 2 | Yes | 7 (35) | 2 (13.4) | 0.083 | 11 (55) | 3 (20) | 0.014 | 2 (8.7) |
| No | 13 (65) | 13 (86.6) | 9 (45) | 12 (80) | 21 (91.3) | |||
| Group 3 | Yes | 13 (65) | 4 (26.7) | 0.005 | 20 (100) | 5 (33.3) | < 0.001 | 5 (20.8) |
| No | 7 (35) | 11 (73.3) | 0 (0) | 10 (66.7) | 19 (79.2) | |||
| P£ | 0.145 | 0.784 | 0.004 | 0.628 | 0.546 | |||
£
Independent samples Kruskal-Wallis test;
€
related-samples Wilcoxon signed rank test. Group 1 – clomiphene citrate (CC), group 2 – herbal mixture, group 3 – CC along with herbal mixture (Clomiphene: Control); Amenorrhea and oligomenorrhea criteria were followed up 3 months after the intervention among women who received no treatment or failed to become pregnant. Pregnancy was determined during a 3-month intervention among women who received the intervention.